Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
AUTOR(ES)
Daughaday, W H
RESUMO
We reported that serum and tumor from a hypoglycemic patient with a fibrosarcoma contained insulin-like growth factor II (IGF-II), mostly in a large molecular form designated "big IGF-II." We now describe two additional patients with non-islet-cell tumor with hypoglycemia (NICTH) whose sera contained big IGF-II. Removal of the tumor eliminated most of the big IGF-II from the sera of two patients. Because specific IGF-binding proteins modify the bioactivity of IGFs, the sizes of the endogenous IGF-binding protein complexes were determined after neutral gel filtration through Saphadex G-200. Normally about 75% of IGFs are carried as a ternary complex of 150 kDa consisting of IGF, a growth hormone (GH)-dependent IGF-binding protein, and an acid-labile complexing component. The three patients with NICTH completely lacked the 150-kDa complex. IGF-II was present as a 60-kDa complex with variable contributions of smaller complexes. In the immediate postoperative period, a 110-kDa complex appeared rather than the expected 150-kDa complex. Abnormal IGF-II binding may be important in NICTH because the 150-kDa complexes cross the capillary membrane poorly. The smaller complexes present in our patients' sera would be expected to enter interstitial fluid readily, and a 4- to 5-fold increase in the fraction of IGFs reaching the target cells would result.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=297929Documentos Relacionados
- Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
- MEASUREMENT OF SMALL QUANTITIES OF INSULIN-LIKE ACTIVITY WITH RAT ADIPOSE TISSUE. IV. SERUM INSULIN-LIKE ACTIVITY AND TUMOR INSULIN CONTENT IN PATIENTS WITH FUNCTIONING ISLET-CELL TUMORS*
- Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
- The receptor for insulin-like growth factor II mediates an insulin-like response.
- Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous.